SEPTILINE
SEPTILINE
Discontinued
DIN Number
00306215
Drug Class
Human
Market Date
Dec 31, 1979
Company
HC
produits francais labs inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00306215
AIG Number0509988001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
Product Specifications
Dosage FormPowder (Effervescent)
Route of AdministrationOral
AHFS Classification56:04.00
Health Canada Classification
ACTIVE INGREDIENTS (5)
POTASSIUM SODIUM TARTRATEActive
Strength: 9.4 MG / G
Monograph: POTASSIUM SODIUM TARTRATE
SODIUM BICARBONATEActive
Strength: 581 MG / G
Monograph: SODIUM BICARBONATE
SODIUM CARBONATE (ANHYDROUS)Active
Strength: 5.4 MG / G
Monograph: SODIUM CARBONATE (ANHYDROUS)
SODIUM CHLORIDEActive
Strength: 10.8 MG / G
Monograph: SODIUM CHLORIDE
TARTARIC ACIDActive
Strength: 392 MG / G
Monograph: TARTARIC ACID